This article is the first in a three-part series on the topic of medicine that is geared toward the individual patient. Part 2 will explore key ethical, legal, and regulatory issues facing the future of personalized medicine, and Part 3 will cover the anticipated challenges in implementing pharmacogenomics and genetic testing into routine clinical practice..